内分泌反应性乳腺癌的生育力保存：数据与偏见
Fertility preservation in endocrine responsive breast cancer: data and prejudices.
作者信息
Buonomoa Barbara, Peccatorib Fedro A
机构信息
https://orcid.org/0000-0001-9921-4639.
https://orcid.org/0000-0001-8227-8740.
出版信息
Ecancermedicalscience. 2020 Dec 18;14:1157. doi: 10.3332/ecancer.2020.1157. eCollection 2020.
Abstract
Even if current guidelines suggest an early referral of young breast cancer (BC) patients to fertility preservation counselling, physicians still lack knowledge about the different available strategies. Hormonal stimulation to harvest mature oocytes is considered unsafe by many oncologists and experts in reproductive medicine, particularly in the setting of oestrogen receptor-positive BC. The aim of this mini-review is to provide an overview on the available data about this topic in order to clarify potential misunderstandings and to highlight the new trends in the oncofertility field with their pros and limitations.
摘要
即使当前指南建议早期将年轻乳腺癌（BC）患者转诊至生育力保存咨询处，但医生们仍缺乏对不同可用策略的了解。许多肿瘤学家和生殖医学专家认为，通过激素刺激获取成熟卵母细胞是不安全的，尤其是在雌激素受体阳性乳腺癌的情况下。本综述的目的是概述有关该主题的现有数据，以澄清潜在的误解，并突出肿瘤生殖领域的新趋势及其优点和局限性。
相似文献
1
Fertility preservation in endocrine responsive breast cancer: data and prejudices.内分泌反应性乳腺癌的生育力保存：数据与偏见
Ecancermedicalscience. 2020 Dec 18;14:1157. doi: 10.3332/ecancer.2020.1157. eCollection 2020.
2
Fertility preservation options in breast cancer patients.乳腺癌患者的生育力保存选择。
Gynecol Endocrinol. 2015;31(11):846-51. doi: 10.3109/09513590.2015.1081684. Epub 2015 Sep 15.
3
The case for aromatase inhibitors use in oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in breast cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate.芳香化酶抑制剂在肿瘤生育力保存患者中的应用情况。在化疗前接受卵巢刺激以保存生育力的乳腺癌患者中，芳香化酶抑制剂是否应与促性腺激素治疗联合使用？一场辩论。
Hum Fertil (Camb). 2013 Dec;16(4):235-40. doi: 10.3109/14647273.2013.800650. Epub 2013 Jul 17.
4
FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER.早期乳腺癌年轻女性的生育力保存
Acta Clin Croat. 2019 Mar;58(1):147-156. doi: 10.20471/acc.2019.58.01.19.
5
Fertility preservation in patients with mutation.携带突变患者的生育力保存
Ecancermedicalscience. 2020 May 6;14:1033. doi: 10.3332/ecancer.2020.1033. eCollection 2020.
6
Beyond fertility preservation: role of the oncofertility unit in the reproductive and gynecological follow-up of young cancer patients.超越生育力保存：oncofertility 单位在年轻癌症患者生殖和妇科随访中的作用。
Hum Reprod. 2019 Aug 1;34(8):1462-1469. doi: 10.1093/humrep/dez108.
7
The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.早期乳腺癌女性生育力保存中控制性卵巢过度刺激的安全性和有效性：一项系统评价
Hum Reprod. 2017 May 1;32(5):1033-1045. doi: 10.1093/humrep/dex027.
8
EUropean REcommendations for female FERtility preservation (EU-REFER): A joint collaboration between oncologists and fertility specialists.EUropean REcommendations for female FERtility preservation (EU-REFER): A joint collaboration between oncologists and fertility specialists.
欧洲女性生育力保护建议（EU-REFER）：肿瘤学家和生育专家的联合协作。
Crit Rev Oncol Hematol. 2019 Jun;138:233-240. doi: 10.1016/j.critrevonc.2019.03.010. Epub 2019 Mar 29.
9
Oncofertility program implementation increases access to fertility preservation options and assisted reproductive procedures for breast cancer patients.肿瘤生育计划的实施增加了乳腺癌患者获得生育力保存选择和辅助生殖程序的机会。
J Surg Oncol. 2017 Feb;115(2):116-121. doi: 10.1002/jso.24418. Epub 2016 Dec 14.
10
Strategies to Maintain Fertility in Young Breast Cancer Patients.维持年轻乳腺癌患者生育能力的策略。
Cancer Treat Res. 2018;173:1-13. doi: 10.1007/978-3-319-70197-4_1.
引用本文的文献
1
Oocyte Quality Assessment in Breast Cancer: Implications for Fertility Preservation.乳腺癌中的卵母细胞质量评估：对生育力保存的影响
Cancers (Basel). 2022 Nov 21;14(22):5718. doi: 10.3390/cancers14225718.
2
Reproductive issues in carriers of germline pathogenic variants in the BRCA1/2 genes: an expert meeting.BRCA1/2基因种系致病变异携带者的生殖问题：一次专家会议
BMC Med. 2021 Sep 10;19(1):205. doi: 10.1186/s12916-021-02081-7.
本文引用的文献
1
ESHRE guideline: female fertility preservation.欧洲人类生殖与胚胎学会指南：女性生育力保存
Hum Reprod Open. 2020 Nov 14;2020(4):hoaa052. doi: 10.1093/hropen/hoaa052. eCollection 2020.
2
Reproductive Outcomes After Breast Cancer in Women With vs Without Fertility Preservation.有生育力保存的与无生育力保存的乳腺癌女性的生殖结局。
JAMA Oncol. 2021 Jan 1;7(1):86-91. doi: 10.1001/jamaoncol.2020.5957.
3
Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines.青春期后癌症患者的生育力保存及治疗后妊娠：ESMO临床实践指南
Ann Oncol. 2020 Dec;31(12):1664-1678. doi: 10.1016/j.annonc.2020.09.006. Epub 2020 Sep 22.
4
Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients.年轻乳腺癌患者肿瘤生育咨询中的热点问题
Breast Cancer (Auckl). 2020 Sep 4;14:1178223420954179. doi: 10.1177/1178223420954179. eCollection 2020.
5
Pregnancy After Breast Cancer in Patients With Germline Mutations.遗传性突变患者的乳腺癌后妊娠。
J Clin Oncol. 2020 Sep 10;38(26):3012-3023. doi: 10.1200/JCO.19.02399. Epub 2020 Jul 16.
6
Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study.采用 GnRH 拮抗剂方案控制性卵巢刺激在年轻乳腺癌女性中进行紧急生育力保存的疗效和安全性：一项前瞻性全国性瑞典多中心研究。
Hum Reprod. 2020 Apr 28;35(4):929-938. doi: 10.1093/humrep/deaa029.
7
ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4).ESO-ESMO 4 版年轻女性乳腺癌国际共识指南（BCY4）。
Ann Oncol. 2020 Jun;31(6):674-696. doi: 10.1016/j.annonc.2020.03.284. Epub 2020 Mar 19.
8
First birth achieved after fertility preservation using vitrification of in vitro matured oocytes in a woman with breast cancer.一名乳腺癌女性通过玻璃化冷冻体外成熟卵母细胞进行生育力保存后首次成功分娩。
Ann Oncol. 2020 Apr;31(4):541-542. doi: 10.1016/j.annonc.2020.01.005. Epub 2020 Feb 18.
9
Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer.BRCA1 和 BRCA2 突变对年轻乳腺癌女性卵巢储备和生育保存结局的影响。
J Assist Reprod Genet. 2020 Mar;37(3):709-715. doi: 10.1007/s10815-019-01658-9. Epub 2019 Dec 24.
10
Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion.接受性腺毒性治疗或性腺切除术的患者的生育力保存：委员会意见。
Fertil Steril. 2019 Dec;112(6):1022-1033. doi: 10.1016/j.fertnstert.2019.09.013.
Zotero 插件